logo-loader
NYSE:ATNM

Actinium Pharmaceuticals Inc

Receive alerts
Market:
NYSE
Market Cap:
$33.28 m
Price
$0.20
Change
-1.77%
52 weeks high
0.87
52 weeks low
0.20

In brief

Actinium is a leading biotechnology company developing targeted radioimmunotherapies for the treatment of cancer patients with unmet needs.